3D Medicines Inc. (01244) reported that, as of 31 October 2025, its authorized share capital remained at 500,000,000 ordinary shares with a par value of HKD 0.001 each, totaling HKD 500,000. The total number of issued shares stood at 258,177,000, with no changes observed during the month.

Under its share option scheme, 12,802,850 outstanding share options remained unchanged, with no new shares issued or treasury shares transferred. Consequently, there was no impact on issued share capital for the reporting period.